Testim® 1% testosterone gel for the treatment of male hypogonadism-Reference-Cited by-同舟云学术

Testim® 1% testosterone gel for the treatment of male hypogonadism

Published:2005-03 Issue:3 Volume:27 Page:286-298
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Bouloux Pierre

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients—2002 update;American Association of Clinical Endocrinologists;Endocr Pract.,2002

2. Andropause: A misnomer for a true clinical entity;Morales;J Urol.,2000

3. Investigation, treatment and monitoring of lateonset hypogonadism in males. Official recommendations of ISSAM;Morales;Aging Male.,2002

4. Disorders of the testes;Griffen,1998

5. Andropause: Clinical implications of the decline in serum testosterone levels with aging in men;Matsumoto;J Gerontol A Biol Sci Med Sci.,2002

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age;Andrology;2021-10-08

2. The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis;BMC Endocrine Disorders;2020-03-07

3. The effect of three-month topical testosterone gel application on semen quality in men with oligozoospermia and low serum testosterone levels;Clinical and Experimental Obstetrics & Gynecology;2020

4. Pharmacokinetics of testosterone cream applied to scrotal skin;Andrology;2017-03-23

5. Testicular Disorders;Williams Textbook of Endocrinology;2016